01 1MediPharm Labs
01 1CANNABIDIOL
01 1Canada
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2022-08-24
Pay. Date : 2022-02-09
DMF Number : 36490
Submission : 2022-02-18
Status : Active
Type : II
20
Medipharm Labs Inc, based in Canada, is a pharmaceutical company that stands out with its certifications from FDA.
They are recognized for Medipharm is a full-service pharmaceutical company delivering high-quality, innovative Cannabis concentrate-based products & services.
One of their notable products is CANNABIDIOL, with a corresponding US DMF Number 36490.
Remarkably, this DMF maintains an Active status since its submission on February 18, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 24, 2022, and payment made on February 09, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
